INDIANAPOLIS — An Indianapolis lab has agreed to pay more than $9 million to resolve allegations that it violated the False Claims Act and the Anti-Kickback Statute with a COVID testing scheme.

According to the U.S. Department of Justice (DOJ), the government alleges that Patients Choice Laboratories (PCL) knowingly submitted claims to Medicare for tests that were either "medically unnecessary" or "obtained through kickbacks."

The government says PCL also paid commissions to independent sales representatives and marketing firms based on the volume or value of referrals.

On Nov. 20, 2020, the government alleges that PCL got into a Marketing Services Agreement (MSA) with an infection prevention company, where PCL agreed to pay $5,000 in exchange for “marketing and management services” in

See Full Page